Research Article
Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Table 3
Calculated age-specific incidence rates, crude rates, and ASR (World), males, Egypt 2008–2011.
| | Site | 0–4 | 5–9 | 10–14 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | 50–54 | 55–59 | 60–64 | 65–69 | 70–74 | 75+ | Crude rate | ASR | % |
| | Lip | — | — | — | — | — | — | 0.5 | — | 0.3 | — | 0.8 | 1.4 | 0.6 | 1.8 | 8.7 | 1.5 | 0.3 | 0.4 | 0.23% | | Tongue | — | — | — | — | — | — | — | — | 0.3 | 1.4 | 1.3 | 3.1 | 1.9 | 1.8 | — | 2.2 | 0.3 | 0.5 | 0.27% | | Mouth | — | — | — | 0.1 | — | — | 0.2 | 0.5 | 0.8 | 1.5 | 2.5 | 4.6 | 0.6 | 2.6 | 1.4 | — | 0.5 | 0.6 | 0.41% | | Salivary glands | — | — | 0.1 | — | 0.1 | — | — | 0.2 | — | — | 0.7 | 1.4 | 2.0 | 2.6 | 4.5 | 5.2 | 0.3 | 0.5 | 0.25% | | Tonsil | — | — | — | — | — | — | — | — | 0.3 | — | — | — | — | — | — | — | — | — | 0.01% | | Other oropharynx | — | — | — | — | 0.1 | — | — | — | — | — | 0.4 | 0.6 | — | 0.8 | 2.8 | — | 0.1 | 0.1 | 0.07% | | Nasopharynx | — | — | — | — | 0.3 | — | — | 0.2 | — | — | 3.4 | 0.4 | — | 3.6 | — | 5.2 | 0.3 | 0.4 | 0.26% | | Hypopharynx | — | — | — | 0.1 | — | — | — | — | 0.3 | — | 0.9 | 1.4 | 0.6 | — | 1.4 | 1.5 | 0.2 | 0.2 | 0.13% | | Pharynx unspec. | — | — | — | — | — | — | 0.2 | — | — | 1.0 | — | — | — | — | — | 1.5 | 0.1 | 0.1 | 0.07% | | Esophagus | — | — | — | — | 0.3 | 0.2 | 0.3 | — | 1.4 | 1.8 | 6.1 | 4.1 | 11.2 | 10.8 | 24.4 | 14.7 | 1.4 | 2.3 | 1.20% | | Stomach | — | 0.1 | 0.1 | — | 0.3 | 0.2 | 0.7 | 0.5 | 2.0 | 2.6 | 5.0 | 6.0 | 11.9 | 6.4 | 21.5 | 14.1 | 1.5 | 2.3 | 1.26% | | Small intestine | 0.1 | — | — | — | — | — | 0.5 | 0.5 | 0.6 | 0.3 | 0.4 | 1.4 | — | 0.8 | — | 1.5 | 0.2 | 0.3 | 0.17% | | Colon | — | — | — | 0.1 | 0.3 | 0.7 | 2.1 | 2.5 | 1.9 | 6.5 | 14.2 | 11.0 | 19.8 | 18.9 | 31.5 | 32.6 | 3.1 | 4.7 | 2.63% | | Rectum | — | — | — | 0.1 | 0.7 | 1.2 | 0.7 | 1.2 | 2.2 | 2.0 | 3.4 | 4.1 | 3.4 | 2.6 | 8.7 | 1.5 | 1.0 | 1.3 | 0.84% | | Anus | — | — | — | — | 0.3 | — | 0.5 | 0.5 | 0.6 | 0.6 | — | 2.1 | 2.0 | 1.0 | — | — | 0.3 | 0.3 | 0.24% | | Liver | 0.3 | 0.4 | 0.4 | 0.2 | 0.3 | 1.3 | 1.4 | 6.1 | 21.2 | 76.3 | 174.2 | 258.7 | 323.1 | 313.8 | 327.1 | 363.5 | 39.5 | 61.8 | 33.63% | | Gallbladder and so forth | — | — | — | — | — | 0.4 | — | 0.5 | 0.6 | 0.6 | 1.0 | 1.0 | 5.9 | 1.0 | 4.7 | 7.4 | 0.5 | 0.7 | 0.40% | | Pancreas | — | — | — | — | — | — | 1.3 | 0.2 | 2.5 | 7.7 | 9.0 | 14.9 | 25.3 | 26.4 | 12.7 | 19.3 | 2.7 | 4.2 | 2.31% | | Nose, sinuses and so forth | — | 0.1 | — | — | — | — | — | 0.5 | 0.3 | — | 1.2 | — | — | — | 1.4 | 8.2 | 0.2 | 0.3 | 0.17% | | Larynx | — | — | — | — | — | — | 0.2 | — | 2.1 | 2.6 | 6.6 | 6.8 | 18.2 | 11.0 | 23.2 | 32.5 | 1.9 | 3.1 | 1.58% | | Trachea, Bronchus, Lung | 0.1 | — | 0.1 | 0.4 | 0.8 | 1.2 | 1.2 | 3.0 | 3.8 | 12.5 | 19.3 | 39.1 | 49.0 | 49.3 | 73.9 | 76.1 | 6.7 | 10.4 | 5.69% | | Other Thoracic organs | 0.3 | — | — | 0.1 | 0.2 | 0.2 | — | — | 0.6 | 1.2 | 2.8 | 3.5 | 3.2 | 7.1 | 9.8 | 8.9 | 0.8 | 1.2 | 0.65% | | Bone | 0.1 | 1.2 | 1.4 | 0.7 | 1.8 | 0.8 | 1.0 | 1.0 | 1.4 | 2.0 | 4.2 | 3.7 | 13.9 | 8.6 | 8.4 | 15.6 | 1.9 | 2.5 | 1.62% | | Melanoma of skin | — | — | — | — | 0.1 | 0.2 | — | — | 0.6 | — | — | 0.4 | — | 1.8 | 2.8 | — | 0.1 | 0.2 | 0.11% | | Other skin | 0.6 | — | 0.1 | — | 0.3 | 0.4 | 0.5 | 0.5 | 1.1 | 0.6 | 3.2 | 4.5 | 14.0 | 14.2 | 18.5 | 30.4 | 1.6 | 2.6 | 1.35% | | Mesothelioma | — | — | — | — | — | — | — | — | — | 0.8 | 0.5 | 1.4 | — | 0.8 | — | — | 0.1 | 0.2 | 0.10% | | Kaposi sarcoma | — | — | — | — | — | — | 0.2 | — | — | — | 1.1 | — | 1.3 | 0.8 | 1.4 | — | 0.1 | 0.2 | 0.10% | | Connective, Soft tissue | 0.3 | 0.1 | 0.1 | 0.6 | 1.1 | 2.0 | 1.3 | 1.3 | 3.1 | 3.5 | 3.6 | 8.3 | 4.6 | 6.1 | 18.8 | 2.2 | 1.7 | 2.2 | 1.47% | | Breast | — | — | — | — | — | 0.4 | — | 0.3 | 2.2 | 0.3 | 2.5 | 3.1 | 3.4 | 3.6 | 2.8 | 5.9 | 0.6 | 0.9 | 0.51% | | Penis | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00% | | Prostate | — | — | — | — | — | 0.2 | 0.3 | — | 0.3 | 1.3 | 4.1 | 11.2 | 24.6 | 47.5 | 90.3 | 216.5 | 5.0 | 9.3 | 4.27% | | Testis | — | 0.1 | — | — | 1.1 | 1.2 | 0.7 | 1.5 | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | — | 1.4 | 2.2 | 0.5 | 0.5 | 0.43% | | Other male genital | — | — | — | — | — | — | — | — | — | — | 0.4 | — | — | 0.8 | 1.4 | — | — | 0.1 | 0.04% | | Kidney | 1.2 | 0.1 | — | — | — | 0.2 | 0.2 | 0.5 | 0.5 | 3.4 | 6.9 | 9.8 | 7.9 | 16.9 | 14.1 | 22.3 | 1.8 | 2.7 | 1.53% | | Renal pelvis | — | — | — | — | 0.1 | — | — | 0.2 | 0.6 | 0.3 | 0.4 | 1.9 | 2.0 | 1.8 | 2.8 | 4.4 | 0.3 | 0.4 | 0.25% | | Ureter | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.4 | 3.0 | — | 0.1 | 0.04% | | Bladder | 0.1 | 0.1 | — | 0.3 | 0.1 | 1.2 | 1.7 | 2.2 | 4.0 | 9.2 | 28.7 | 68.4 | 97.2 | 128.6 | 194.8 | 205.6 | 12.6 | 21.1 | 10.71% | | Other urinary organs | — | — | — | — | — | — | — | — | — | — | — | — | 0.6 | — | — | — | — | — | 0.01% | | Eye | 0.5 | 0.3 | — | — | — | — | — | — | — | 0.4 | 0.4 | 1.8 | 0.6 | — | — | — | 0.2 | 0.2 | 0.16% | | Brain, Nervous tissue | 2.9 | 3.0 | 1.8 | 1.7 | 1.5 | 3.3 | 4.2 | 6.8 | 7.3 | 7.3 | 15.5 | 14.5 | 27.2 | 30.4 | 46.7 | 91.4 | 6.4 | 9.0 | 5.48% | | Thyroid | — | — | — | — | 0.2 | 0.8 | 1.2 | 1.9 | 1.1 | 3.2 | 4.5 | 4.3 | 6.6 | 8.7 | 3.0 | — | 1.1 | 1.5 | 0.95% | | Adrenal gland | 0.3 | 0.1 | — | — | — | — | — | — | — | — | — | 0.6 | — | 0.8 | 1.4 | — | 0.1 | 0.1 | 0.08% | | Other endocrine | 0.5 | — | 0.1 | — | 0.3 | — | — | 0.5 | 0.3 | 1.0 | 0.4 | 1.3 | 0.6 | — | 2.8 | — | 0.3 | 0.4 | 0.25% | | Hodgkin disease | 0.5 | 1.7 | 1.7 | 1.5 | 1.5 | 1.4 | — | 0.2 | 1.7 | 2.5 | 2.0 | 1.4 | 5.3 | 6.1 | 2.8 | 1.5 | 1.5 | 1.7 | 1.29% | | Non-Hodgkin lymphoma | 1.1 | 1.2 | 1.5 | 1.0 | 2.2 | 2.5 | 2.1 | 3.6 | 5.8 | 16.6 | 24.4 | 36.0 | 33.8 | 29.5 | 38.1 | 28.8 | 6.4 | 8.8 | 5.48% | | Immunoproliferative dis. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00% | | Multiple myeloma | — | — | — | — | — | — | 0.5 | 0.5 | 1.1 | 0.4 | 3.1 | 3.9 | 8.0 | 0.8 | 2.8 | 2.9 | 0.6 | 0.9 | 0.53% | | Lymphoid leukemia | 3.9 | 2.2 | 0.7 | 0.2 | 1.4 | — | 0.7 | 1.5 | 1.1 | 1.8 | 1.5 | 5.0 | 6.0 | 8.9 | 5.6 | — | 1.8 | 2.1 | 1.50% | | Myeloid Leukemia | 0.8 | 0.4 | 0.3 | 0.8 | 1.0 | 0.4 | 1.1 | 0.7 | 1.4 | 1.8 | 4.2 | 3.3 | 3.4 | 2.6 | 4.5 | 1.5 | 1.1 | 1.3 | 0.96% | | Leukemia unspec. | 1.0 | 1.2 | 1.1 | 0.6 | 2.1 | 2.2 | 1.7 | 0.5 | 2.1 | 4.7 | 1.8 | 6.0 | 8.0 | 3.5 | 7.3 | 20.8 | 2.1 | 2.6 | 1.80% | | Other & unspecified | 2.4 | 2.8 | 0.9 | 1.7 | 1.3 | 1.8 | 3.3 | 3.1 | 6.1 | 15.0 | 22.9 | 25.2 | 44.9 | 54.7 | 64.7 | 83.6 | 7.6 | 11.2 | 6.52% |
| | All sites Total | 17.1 | 15.4 | 10.5 | 10.5 | 20.1 | 23.9 | 30.6 | 42.8 | 83.8 | 195.4 | 389.6 | 582.4 | 793.5 | 840.2 | 1096.1 | 1335.6 | 117.3 | 178.5 | 100.00% | | All sites but C44# | 16.6 | 15.4 | 10.4 | 10.5 | 19.8 | 23.5 | 30.0 | 42.4 | 82.7 | 194.9 | 386.4 | 577.9 | 779.5 | 826.0 | 1077.5 | 1305.3 | 115.7 | 175.9 | 98.65% |
|
|
Incidence rates do not include nonmelanoma skin cancer.
|
